Editor's Correspondence |

Inability of Speculation to Explain Dose Effect Differences Between Botulinum Toxin Products

Andy Pickett, PhD, BSc
Arch Facial Plast Surg. 2012;14(6):467-468. doi:10.1001/jamafacial.2013.366.
Text Size: A A A
Published online


The recent publication from Yu et al,1 examining 2 botulinum toxin products for the treatment of lateral orbital rhytids, shows an apparent clinical distinction between the products. AbobotulinumtoxinA (Dysport; Medicis) demonstrated a trend toward greater improvement at day 2 and statistically significant improvements at days 4 and 6, all at maximum contraction.1 This report seems to be almost a duplicate of that previously published by the same group,2 but the number of injection points has been reduced from 5 to 4 in the later report.1 The 2 studies seem to be part of the same trial.1

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Validity of Botulinum Neurotoxin Serotype H. J Infect Dis Published online Apr 10, 2014.;